Stoke Therapeutics Management
How experienced are the management team and are they aligned to shareholders interests?
3.9yrs
Average management tenure
CEO
Ed Kaye (73 yo)
5.33yrs
Tenure
US$8,543,358
Compensation
Dr. Edward M. Kaye, also known as Ed, M.D., Ph.D. has been Special Regulatory and Scientific Advisor of Sarepta Therapeutics, Inc. since June 28, 2017. He serves as Independent Director at Avidity Bioscien...
CEO Compensation Analysis
| Date | Total Comp. | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$100m |
| Jun 30 2022 | n/a | n/a | -US$96m |
| Mar 31 2022 | n/a | n/a | -US$94m |
| Dec 31 2021 | US$9m | US$568k | -US$86m |
| Sep 30 2021 | n/a | n/a | -US$76m |
| Jun 30 2021 | n/a | n/a | -US$67m |
| Mar 31 2021 | n/a | n/a | -US$58m |
| Dec 31 2020 | US$5m | US$549k | -US$52m |
| Sep 30 2020 | n/a | n/a | -US$48m |
| Jun 30 2020 | n/a | n/a | -US$43m |
| Mar 31 2020 | n/a | n/a | -US$38m |
| Dec 31 2019 | US$668k | US$477k | -US$32m |
| Sep 30 2019 | n/a | n/a | -US$26m |
| Jun 30 2019 | n/a | n/a | -US$21m |
| Mar 31 2019 | n/a | n/a | -US$16m |
| Dec 31 2018 | US$1m | US$464k | -US$13m |
Compensation vs Market: Ed's total compensation ($USD8.54M) is above average for companies of similar size in the US market ($USD2.45M).
Compensation vs Earnings: Ed's compensation has increased whilst the company is unprofitable.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.33yrs | US$8.54m | 0.063% $ 237.5k | |
| Co-Founder | no data | US$378.03k | 1.03% $ 3.8m | |
| Chief Financial Officer | 3.92yrs | US$3.10m | 0.030% $ 111.7k | |
| Chief Medical Officer | 5.33yrs | US$3.15m | 0.32% $ 1.2m | |
| Co-Founder & Group VP of Discovery Research | no data | no data | no data | |
| COO & Chief Business Officer | 5.33yrs | US$869.86k | no data | |
| Head of Investor Relations | no data | no data | no data | |
| General Counsel | 2.08yrs | no data | no data | |
| Chief Communications Officer | 2.08yrs | no data | no data | |
| Chief Human Resources Officer | 3.33yrs | no data | no data | |
| Chief Regulatory Officer | 4.17yrs | no data | no data | |
| Senior Vice President of Development Operations | 2.08yrs | no data | no data |
3.9yrs
Average Tenure
61yo
Average Age
Experienced Management: STOK's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.33yrs | US$8.54m | 0.063% $ 237.5k | |
| Co-Founder | 8.67yrs | US$378.03k | 1.03% $ 3.8m | |
| Independent Chairman of the Board | 7.58yrs | US$372.03k | 4.76% $ 17.8m | |
| Independent Director | 7.42yrs | US$340.53k | 0.046% $ 170.8k | |
| Independent Director | 2.5yrs | US$334.03k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.08yrs | no data | no data | |
| Independent Director | 2.67yrs | US$334.03k | 0% $ 0 | |
| Independent Director | 3.67yrs | US$344.03k | 0% $ 0 | |
| Independent Director | 4.42yrs | US$346.53k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.08yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.08yrs | no data | no data |
3.7yrs
Average Tenure
62yo
Average Age
Experienced Board: STOK's board of directors are considered experienced (3.7 years average tenure).